Day: March 13, 2023

Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy

SHANGHAI, March 14, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”) announced today that its partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) reported positive topline results from the global, randomized, double-blind, placebo-controlled Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon versus placebo in patients with primary […]

The Damned Announce 2023 Australian Tour

Having been revealed as one of the headliners of Melbourne’s RISING festival, UK punk outfit The Damned have announced a full Australian tour for 2023. They’ll kick things off in Adelaide on Monday, 5th of June, before moving through Brisbane and Sydney. They’ll perform a show in Melbourne as part of RISING festival at the […]

AnnJi Pharmaceutical Announced Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Kennedy’s Disease Treatment

TAIPEI, March 14, 2023 /PRNewswire/ — AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S., Canada, European Union, Great Britain, and Israel for spinal and bulbar muscular atrophy (SBMA), also known as Kennedy’s Disease. Under the […]

Asendia Launches e-PAQ Select for Oceania E-commerce Market

Asendia’s new, economically optimised and faster delivery service provides an efficient and cost-effective alternative for e-commerce logistics in Australia and New Zealand SYDNEY, March 14, 2023 /PRNewswire/ — Asendia, one of the world’s leading e-commerce logistics providers, is introducing e-PAQ Select, a new and improved tracked delivery solution for Oceania market. Unlike the existing e-PAQ […]

Telix’s ZIRCON Phase III Kidney Cancer Imaging Study Presented in “Game Changing” Session at EAU

MELBOURNE, Australia, March 14, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) ( Identifier: NCT03849118).1 The results were featured in a “Game Changing” oral session delivered by Professor Dr. […]

Yalla Group Limited Announces Unaudited Fourth Quarter and Full Year 2022 Financial Results

DUBAI, UAE, March 14, 2023 /PRNewswire/ — Yalla Group Limited (“Yalla” or the “Company”) (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Financial and Operating Highlights Revenues were […]

Baijiayun Group Ltd Completes Transition into a Pure-play RTC Provider with Divestiture of Fuwei Films

BEIJING, March 14, 2023 /PRNewswire/ — Baijiayun Group Ltd (“Baijiayun” or the “Company”) (Nasdaq: RTC), a video-centric technology solution provider with core expertise in SaaS/PaaS solutions, today announced that on March 9, 2023, it entered into a securities purchase agreement (the “SPA”) with Aoji Holdings Co., Ltd (“Aoji” or the “Purchaser”) to divest the Company’s 100% […]

Back To Top